ArticleFrontiers in psychiatry2026
Paranoia, experiential avoidance, and narcissism as predictors of outcome in residential treatment of borderline personality disorder.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Previous research has suggested that residential treatment may be effective in reducing symptoms in patients with symptoms of borderline personality disorder (BPD). This study examined whether paranoia, experiential avoidance, and narcissistic personality features predicted response to residential treatment in a cohort of female patients with symptoms of borderline personality disorder. Method: Participants were 87 women with borderline personality disorder symptoms who participated in multimodal residential treatment incorporating elements of Dialectical Behavioral Therapy, Mentalization Based Therapy, Transference Focused Psychotherapy, and General Psychiatric Management. All participants met definite or probable criteria for borderline personality disorder as assessed by the International Personality Disorder Examination. Participants were evaluated at baseline and at one-month intervals using the Zanarini Rating Scale for Borderline Personality Disorder, Self-Report Version (Zan-BPD, SR), the Paranoid Thoughts Scale (PTS), the Multidimensional Experiential Avoidance Questionnaire (MEAQ), and the Narcissistic Personality Inventory (NPI). The primary outcome measure was change in mean ZAN-BPD scores. Results: Mean scores on the ZAN-BPD (11 to 7, p<0.001), the PTS (2.4 to 2, p<0.001), the Distress Tolerance Subscale of the MEAQ (3.4 to 2.8, p<0.001), and NPI (1.4 to 1.3, p=0.04) all decreased over time. Higher baseline mean scores on the Social Reference subscale of the PTS and the Distress Aversion Subscale of the MEAQ were associated with larger and faster declines in mean ZAN-BPD scores. Baseline scores on the Behavioral Avoidance subscale of the MEAQ were associated with slower declines in mean ZAN-BPD scores. Longitudinal declines in the Distress Aversion subscale of the MEAQ and the Social Reference subscale of the PTS were significantly associated with reductions in mean ZAN-BPD scores over time. NPI scores were not significantly associated with changes in ZAN-BPD scores. Conclusion: Multimodal residential treatment may be an effective treatment for female patients with borderline personality disorder. Paranoia and experiential avoidance may not be negative prognostic factors in the treatment of such patients and should be considered significant residential treatment targets. Narcissistic personality features may change more slowly and appear to be less influential in residential treatment for borderline personality disorder.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.